Reaching Impact Saturation and Epidemic Control (RISE)

• Reaching Impact Saturation and Epidemic Control (RISE) is a multi-country project funded by the U.S. Government to save lives and improve health through integrated, evidence-based approaches to address urgent gaps in lifesaving services. RISE works across all levels of the health system to strengthen the HIV/TB epidemic response, to limit the spread of deadly disease outbreaks through Global Health Security programming, and to reduce preventable morbidity and mortality through integrated maternal, newborn, and child health, nutrition, tuberculosis, and malaria services. RISE supports country governments to strengthen essential data systems, supply chain and commodity management, human resources for health, domestic resource mobilization, and other cross-cutting health system functions to accelerate transition to country ownership. Since 2019, RISE has supported programs in more than 25 countries across Africa, Asia, and Latin America. The program runs through December 2027. Learn more here.

MOMENTUM Country and Global Leadership

• MOMENTUM Country and Global Leadership, funded by the United States Government, is a global mechanism that saves lives and improves access to quality, integrated health services by distributing life-saving commodities, medicines, and vaccines, and providing critical health care services for pregnant mothers and children under five. The project provides safe childbirth for mothers and babies, vaccinates children, treats deadly illnesses and malnutrition, and controls disease outbreaks.

  Learn more here: Momentum Country and Global Leadership

Supported by GAVI, the HPV Vaccine project aims to strengthen routine vaccination coverage of the Expanded Program on Immunization (EPI), with a particular focus on human papillomavirus (HPV) vaccination, the primary cause of cervical cancer.

• Jhpiego’s efforts are part of a broader strategy to reduce the number of zero-dose children and girls, as well as under-vaccinated populations, in order to ensure equitable and sustainable protection against vaccine-preventable diseases.

• We support the introduction of new vaccines and facilitate the development of guidelines and training to ensure quality vaccination services. Additionally, we advocate for the integration of HPV vaccination into routine medical visits and work to strengthen community engagement to reduce the number of zero-dose and under-immunized children.

• We advocate for the introduction of new vaccines while facilitating the development of guidelines and training to ensure high-quality vaccination services. Furthermore, we promote the integration of HPV vaccination into routine medical visits and strive to enhance community engagement to decrease the incidence of zero-dose and under-immunized children.